You are here: Home > Prescription(RX) Drugs > A > Acetasol Hc (Actavis Mid Atlantic Llc)

Name:Acetasol Hc
Manufacturer:Actavis Mid Atlantic Llc
Category:Prescription Marketed Drugs


HYDROCORTISONE AND ACETIC ACID OTIC SOLUTION USP FORM 0882 VC2767 Rev. 2/06 Rx Only

ACETASOL HC - hydrocortisone and acetic acid solution 
Actavis Mid Atlantic LLC

----------

HYDROCORTISONE AND ACETIC ACID OTIC SOLUTION USP

FORM 0882
VC2767
Rev. 2/06

Rx Only

DESCRIPTION

Hydrocortisone and Acetic Acid Otic Solution USP, is a solution containing hydrocortisone (1%) and acetic acid (2%), in a propylene glycol vehicle containing propylene glycol diacetate (3%), benzethonium chloride (0.02%), sodium acetate (0.015%), and citric acid (0.2%). The molecular formulas for acetic acid and hydrocortisone are C2H4O2 and C21H30O5, with molecular weights of 60.05 and 362.46, respectively. The structural formulas are:

Image from Drug Label Content

Chemically, hydrocortisone is: Pregn-4-ene-3,20-dione, 11,17,21-trihydroxy-(11ß)-.

Image from Drug Label Content

This product is available as a nonaqueous otic solution buffered at pH 2 to 4 for use in the external ear canal.

CLINICAL PHARMACOLOGY

Acetic acid is anti-bacterial and anti-fungal; hydrocortisone is anti-inflammatory, anti-allergic and anti-pruritic; propylene glycol is hydrophilic and provides a low surface tension; benzethonium chloride is a surface active agent that promotes contact of the solution with tissues.

INDICATIONS AND USAGE

For the treatment of superficial infections of the external auditory canal caused by organisms susceptible to the action of the antimicrobial, complicated by inflammation.

CONTRAINDICATIONS

Hypersensitivity to any of the ingredients, herpes simplex, vaccinia and varicella. Perforated tympanic membrane is considered a contraindication to the use of any medication in the external ear canal.

WARNINGS

Discontinue promptly if sensitization or irritation occurs.

PRECAUTIONS

Transient stinging or burning may be noted occasionally when the solution is first instilled into the acutely inflamed ear.

Pediatric Use

Safety and effectiveness in pediatric patients below the age of 3 years have not been established.

ADVERSE REACTIONS

Stinging or burning may be noted occasionally; local irritation has occurred very rarely.

DOSAGE AND ADMINISTRATION

Carefully remove all cerumen and debris to allow solution to contact infected surfaces directly. To promote continuous contact, insert a wick of cotton saturated with the solution into the ear canal; the wick may also be saturated after insertion. Instruct the patient to keep the wick in for at least 24 hours and to keep it moist by adding 3 to 5 drops of solution every 4 to 6 hours. The wick may be removed after 24 hours but the patient should continue to instill 5 drops of solution 3 or 4 times daily thereafter, for as long as indicated. In pediatric patients, 3 to 4 drops may be sufficient due to the smaller capacity of the ear canal.

HOW SUPPLIED

Hydrocortisone and Acetic Acid Otic Solution USP, 1%/2% is available in a 10 mL measured-drop, safety-tip plastic bottle.

Store at controlled room temperature 20°-25°C (68°-77°F).

Keep container tightly closed.

Manufactured by:

Actavis Mid Atlantic LLC

7205 Windsor Blvd.

Baltimore, MD 21244 USA

FORM NO. 0882

Rev. 2/06

VC2767


ACETASOL HC 
hydrocortisone and acetic acid otic solution
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:0472-0882
Route of Administration AURICULAR (OTIC) DEA Schedule     
INGREDIENTS
Name (Active Moiety) Type Strength
hydrocortisone (hydrocortisone) Active 1 PERCENT  In 10 MILLILITER
acetic acid (acetic acid) Active 2 PERCENT  In 10 MILLILITER
propylene glycol diacetate Inactive  
benzethonium chloride Inactive  
sodium acetate Inactive  
citric acid Inactive  
Product Characteristics
Color      Score     
Shape Size
Flavor Imprint Code
Contains     
Packaging
# Item Code Package Description Multilevel Packaging
1 0472-0882-82 1 BOTTLE In 1 CARTON contains a BOTTLE
1 10 mL (MILLILITER) In 1 BOTTLE This package is contained within the CARTON (0472-0882-82)

Revised: 03/2009 Actavis Mid Atlantic LLC



Source: http://dailymed.nlm.nih.gov
Reproduced with permission of U.S. National Library of Medicine


Copyright © 2017 Drugsdb.eu by Dionisios Fentas || Terms of Use

Loading

Prescription Marketed Drugs Alphabetically
A| B| C| D| E| F| G| H| I| J| K| L| M| N| O| P| Q| R| S| T| U| V| W| X| Y| Z| 0-9

Categories:
Prescription(RX) Drugs
Over-the-counter (OTC) Drugs
Homeopathic Drugs
Animal Drugs
Feedback